Key facts
- This page summarizes Joshua L. Proffitt's Form 4 filing for LHC Group, Inc.
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 22 Feb 2023, 15:32.
Joshua L. Proffitt - 22 Feb 2023 Form 4 Insider Report for LHC Group, Inc
- Reporting relationship
- President and COO
- Issuer ticker
- N/A
- Reported as of
- 22 Feb 2023
- Net transaction value
- -$7,809,290
- SEC form
- 4
- Accepted by SEC
- 22 Feb 2023, 15:32:42 UTC
- Prior SEC filing
- 02 Feb 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Maria Wiggins, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Joshua L. Proffitt filed Form 4 for LHC Group, Inc on 22 Feb 2023.
Change
- Previous filing in this sequence was filed on 02 Feb 2023.
- Current net transaction value: -$7,809,290.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LHCG
transaction
Common Stock
Disposed to Issuer
- Transaction value
- $0
- Shares
- -71,506
- Change %
- -61%
- Price
- $0.000000
- Shares after
- 45,937
- Date
- 22 Feb 2023
- Ownership
- Direct
- Footnotes
- F1
LHCG
transaction
Common Stock
Disposed to Issuer
- Transaction value
- $7,809,290
- Shares
- -45,937
- Change %
- -100%
- Price
- $170.00
- Shares after
- 0
- Date
- 22 Feb 2023
- Ownership
- Direct
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Joshua L. Proffitt is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 2 footnotes
Footnote F1
Each share of issuer restricted common stock was disposed of pursuant to the merger agreement (the "Merger Agreement") between the issuer and UnitedHealth Group Incorporated ("UnitedHealth") in exchange for 0.3452973658492390 shares of UnitedHealth restricted common stock having a market value of $492.329269821954 per share as determined pursuant to the Merger Agreement, which shares of UnitedHealth restricted common stock shall continue to be governed by the same terms and conditions (including vesting terms) as were applicable to such shares of issuer restricted common stock.
Footnote F2
Each share of issuer common stock was cancelled pursuant to Merger Agreement in exchange for a cash payment equal to $170.00.